Oregon Clinical Research is categorized under Commercial Medical Research in Happy Valley, OR and active since 1995.
Oregon Clinical Research was established in 1995, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Terri Eichorn at the company’s single location by writing to 13219 Se Evening Star Drive, Happy Valley, Oregon OR 97086 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oregon Clinical Research |
| Contact Person: | Terri Eichorn |
| Address: | 13219 Se Evening Star Drive, Happy Valley, Oregon 97086 |
| Website Address: | oregonclinicalresearch.net |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Oregon Clinical Research was started in 1995 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Terri Eichorn for inquiries that concern Oregon Clinical Research by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Oregon Clinical Research can be found at the coordinates 45.440787,-122.528215 as well as the street address 13219 Se Evening Star Drive in Happy Valley, Oregon 97086.
For its online presence, you may visit Oregon Clinical Research’s website at oregonclinicalresearch.net and engage with its social media outlets through on Twitter and on Facebook.